What is murine typhus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Murine Typhus?

Murine typhus is a flea-borne rickettsial infection caused by Rickettsia typhi, transmitted primarily by rat fleas (Xenopsylla cheopis) and cat fleas (Ctenocephalides felis), presenting as an acute febrile illness that can range from mild to life-threatening. 1, 2

Causative Agent and Transmission

Murine typhus is caused by Rickettsia typhi, an obligately intracellular gram-negative coccobacillus 2. The disease follows a specific transmission cycle:

  • Primary reservoir: Rats (Rattus species) serve as the natural reservoir 2
  • Vector: Rat fleas (Xenopsylla cheopis) are the classical vector 1
  • Alternative cycle: In Texas and Southern California, an alternate transmission cycle involves opossums (Didelphis virginiana) and cat fleas (Ctenocephalides felis) 2
  • Human infection: Occurs when R. typhi-infected flea feces are rubbed into flea bite wounds or onto mucous membranes 2

Geographic Distribution

Murine typhus is endemic throughout tropical and subtropical regions worldwide, particularly in seaboard regions and port cities where rodent populations are dense. 1, 2 The disease is reemerging as an increasingly recognized cause of febrile illness in the United States, especially in Texas and Southern California 3, 2.

Clinical Presentation

Incubation Period

Five to 7 days (up to 10 days) 1

Common Manifestations

The disease typically presents as an undifferentiated febrile illness with:

  • Fever (present in >80% of cases) 1
  • Headache 1, 2
  • Myalgia 1, 2
  • Malaise 2
  • Maculopapular rash (approximately 50% of cases) 3

Severity Spectrum

While often considered mild, the disease can be severe:

  • Mild cases: Symptoms can last up to 3 weeks when untreated 3
  • Severe manifestations: Include pneumonitis, acute kidney injury, meningoencephalitis, and multi-organ involvement 3, 2, 4
  • Atypical presentations: Can mimic acute cholangitis with biliary dysfunction, septic shock, or present predominantly with gastrointestinal symptoms 5, 6, 7

Mortality and Complications

Murine typhus can be fatal, with historical mortality rates of 0.4%, though recent data from Southern California shows case fatality rates of 1.8%. 3 Mortality rates can reach up to 32% in severe cases 1.

A critical emerging complication is hemophagocytic lymphohistiocytosis (HLH), a life-threatening hyperinflammatory syndrome that has been increasingly reported with murine typhus 3.

Diagnostic Challenges

The disease is frequently underrecognized and misdiagnosed due to its non-specific clinical presentation, leading to underreporting and delayed treatment. 4 Key diagnostic pitfalls include:

  • Symptoms overlap with many other febrile illnesses
  • Antibodies are seldom detectable in the first week of illness 2
  • Serology requires demonstrating seroconversion or fourfold increase in antibody titer between acute and convalescent sera 2
  • The complexity of clinical presentation obscures true transmission dynamics 4

Treatment Implications

Early empiric treatment with doxycycline is imperative when murine typhus is suspected, as diagnostic confirmation typically requires convalescent serology. 2 The disease responds to fluoroquinolones or azithromycin as alternatives 1, and patients should respond within 24-48 hours of appropriate antibiotic therapy 1.

Public Health Significance

Murine typhus represents an important emerging and reemerging infectious disease 2, 4. Every person with pets that might have fleas is susceptible 5. The rising incidence in endemic areas of the United States reinforces the importance of clinical awareness of both typical and atypical presentations to allow early appropriate treatment and avoid unnecessary interventions 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.